{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:10:37Z","timestamp":1793398237664,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In contrast to acute peripheral nerve injury, the molecular response of Schwann cells in chronic neuropathies remains poorly understood. Onion bulb structures are a pathological hallmark of demyelinating neuropathies, but the nature of these formations is unknown. Here, we show that Schwann cells induce the expression of Neuregulin-1 type I (NRG1-I), a paracrine growth factor, in various chronic demyelinating diseases. Genetic disruption of Schwann cell-derived NRG1 signalling in a mouse model of Charcot-Marie-Tooth Disease 1A (CMT1A), suppresses hypermyelination and the formation of onion bulbs. Transgenic overexpression of NRG1-I in Schwann cells on a wildtype background is sufficient to mediate an interaction between Schwann cells via an ErbB2 receptor-MEK\/ERK signaling axis, which causes onion bulb formations and results in a peripheral neuropathy reminiscent of CMT1A. We suggest that diseased Schwann cells mount a regeneration program that is beneficial in acute nerve injury, but that overstimulation of Schwann cells in chronic neuropathies is detrimental.<\/jats:p>","DOI":"10.1038\/s41467-019-09385-6","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T07:29:55Z","timestamp":1554103795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-7958","authenticated-orcid":false,"given":"Robert","family":"Fledrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Akkermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Sch\u00fctza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-7379","authenticated-orcid":false,"given":"Tamer A.","family":"Abdelaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-093X","authenticated-orcid":false,"given":"Doris","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sch\u00e4ffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Clara","family":"Soto-Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"G\u00f6tze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Klink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Kusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kungl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Frydrychowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2902-7165","authenticated-orcid":false,"given":"Wiebke","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf C.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Bechmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Sereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2477-2892","authenticated-orcid":false,"given":"Markus H.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Armin","family":"Nave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Stassart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"9385_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature09614","volume":"468","author":"KA Nave","year":"2010","unstructured":"Nave, K.-A. Myelination and support of axonal integrity by glia. Nature 468, 244\u2013252 (2010).","journal-title":"Nature"},{"key":"9385_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","volume":"6","author":"H Skre","year":"1974","unstructured":"Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease. Clin. Genet. 6, 98\u2013118 (1974).","journal-title":"Clin. Genet."},{"key":"9385_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng0692-166","volume":"1","author":"LJ Valentijn","year":"1992","unstructured":"Valentijn, L. J. et al. The peripheral myelin gene PMP\u201322\/GAS\u20133 is duplicated in Charcot\u2013Marie\u2013Tooth disease type 1A. Nat. Genet. 1, 166\u2013170 (1992).","journal-title":"Nat. Genet."},{"key":"9385_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng0692-171","volume":"1","author":"V Timmerman","year":"1992","unstructured":"Timmerman, V. et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat. Genet. 1, 171\u2013175 (1992).","journal-title":"Nat. Genet."},{"key":"9385_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12035-012-8370-x","volume":"47","author":"J Li","year":"2013","unstructured":"Li, J., Parker, B., Martyn, C., Natarajan, C. & Guo, J. The PMP22 gene and its related diseases. Mol. Neurobiol. 47, 673\u2013698 (2013).","journal-title":"Mol. Neurobiol."},{"key":"9385_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","volume":"8","author":"D Pareyson","year":"2009","unstructured":"Pareyson, D. & Marchesi, C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet 8, 654\u2013667 (2009).","journal-title":"Lancet"},{"key":"9385_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1529-8027.2008.00182.x","volume":"13","author":"EM Yiu","year":"2008","unstructured":"Yiu, E. M., Burns, J., Ryan, M. M. & Ouvrier, R. A. Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A. J. Peripher. Nerv. Syst. 13, 236\u2013241 (2008).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"9385_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/BF00318579","volume":"90","author":"aa Gabre\u00ebls-Festen","year":"1995","unstructured":"Gabre\u00ebls-Festen, aa et al. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol. 90, 645\u2013649 (1995).","journal-title":"Acta Neuropathol."},{"key":"9385_CR9","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1093\/brain\/awp274","volume":"132","author":"MA Saporta","year":"2009","unstructured":"Saporta, M. A. et al. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain 132, 3263\u20133273 (2009).","journal-title":"Brain"},{"key":"9385_CR10","first-page":"209","volume":"5","author":"P Marie","year":"1918","unstructured":"Marie, P. & Bertrand, I. Contribution a l\u2019anatomie pathologique de la n\u00e9vrite hypertrophique familial. Ann. Med. 5, 209\u2013258 (1918).","journal-title":"Ann. Med."},{"key":"9385_CR11","first-page":"742","volume":"41","author":"PJ Dyck","year":"1966","unstructured":"Dyck, P. J. Histologic measurements and fine structure of biopsied sural nerve: normal, and in peroneal muscular atrophy, hypertrophic neuropathy, and congenital sensory neuropathy. Mayo Clin. Proc. 41, 742\u2013774 (1966).","journal-title":"Mayo Clin. Proc."},{"key":"9385_CR12","doi-asserted-by":"crossref","unstructured":"Bilbao Juan, M. & Schmidt, R. Biopsy Diagnosis of Peripheral Neuropathy (Springer, Cham, 2015).","DOI":"10.1007\/978-3-319-07311-8"},{"key":"9385_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archneur.1972.00490100019001","volume":"26","author":"DE Pleasure","year":"1972","unstructured":"Pleasure, D. E. & Towfighi, J. Onion bulb neuropathies. Arch. Neurol. 26, 289\u2013301 (1972).","journal-title":"Arch. Neurol."},{"key":"9385_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/archneur.1969.00480130087010","volume":"21","author":"PJ Dyck","year":"1969","unstructured":"Dyck, P. J. Experiences in hypertrophic neuropathy. Pathogenesis of onion-bulb formations produced by repeated tourniquet applications. Arch. Neurol. 21, 73\u201395 (1969).","journal-title":"Arch. Neurol."},{"key":"9385_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0022-510X(75)90257-9","volume":"24","author":"JD Pollard","year":"1975","unstructured":"Pollard, J. D., King, R. H. & Thomas, P. K. Recurrent experimental allergic neuritis. An electron microscope study. J. Neurol. Sci. 24, 365\u2013383 (1975).","journal-title":"J. Neurol. Sci."},{"key":"9385_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nm.3664","volume":"20","author":"R Fledrich","year":"2014","unstructured":"Fledrich, R. et al. Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nat. Med. 20, 1055\u20131061 (2014).","journal-title":"Nat. Med."},{"key":"9385_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/glia.22638","volume":"62","author":"D Klein","year":"2014","unstructured":"Klein, D., Groh, J., Wettmarshausen, J. & Martini, R. Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulation. Glia 62, 736\u2013750 (2014).","journal-title":"Glia"},{"key":"9385_CR18","first-page":"1","volume":"0","author":"KR Jessen","year":"2016","unstructured":"Jessen, K. R. & Mirsky, R. The repair Schwann cell and its function in regenerating nerves. J. Physiol. 0, 1\u201311 (2016).","journal-title":"J. Physiol."},{"key":"9385_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neuron.2011.11.031","volume":"73","author":"I Napoli","year":"2012","unstructured":"Napoli, I. et al. A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73, 729\u2013742 (2012).","journal-title":"Neuron"},{"key":"9385_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuron.2012.06.021","volume":"75","author":"PJ Arthur-Farraj","year":"2012","unstructured":"Arthur-Farraj, P. J. et al. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75, 633\u2013647 (2012).","journal-title":"Neuron"},{"key":"9385_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.conb.2006.08.008","volume":"16","author":"KA Nave","year":"2006","unstructured":"Nave, K.-A. & Salzer, J. L. Axonal regulation of myelination by neuregulin 1. Curr. Opin. Neurobiol. 16, 492\u2013500 (2006).","journal-title":"Curr. Opin. Neurobiol."},{"key":"9385_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","volume":"284","author":"DL Falls","year":"2003","unstructured":"Falls, D. L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 284, 14\u201330 (2003).","journal-title":"Exp. Cell Res."},{"key":"9385_CR23","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/glia.20753","volume":"56","author":"C Birchmeier","year":"2008","unstructured":"Birchmeier, C. & Nave, K.-A. Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56, 1491\u20131497 (2008).","journal-title":"Glia"},{"key":"9385_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.1095862","volume":"304","author":"GV Michailov","year":"2004","unstructured":"Michailov, G. V. et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700\u2013703 (2004).","journal-title":"Science"},{"key":"9385_CR25","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1523\/JNEUROSCI.1681-09.2010","volume":"30","author":"N Syed","year":"2010","unstructured":"Syed, N. et al. Soluble neuregulin-1 has bi-functional, concentration-dependent effects on Schwann cell myelination. J. Neurosci. 30, 6122\u20136131 (2010).","journal-title":"J. Neurosci."},{"key":"9385_CR26","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1523\/JNEUROSCI.23-19-07269.2003","volume":"23","author":"RP Huijbregts","year":"2003","unstructured":"Huijbregts, R. P., Roth, K. A., Schmidt, R. E. & Carroll, S. L. Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth factor beta3 in myelinating Schwann cells. J. Neurosci. 23, 7269\u20137280 (2003).","journal-title":"J. Neurosci."},{"key":"9385_CR27","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1523\/JNEUROSCI.2568-10.2011","volume":"31","author":"FR Fricker","year":"2011","unstructured":"Fricker, F. R. et al. Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood. J. Neurosci. 31, 3225\u20133233 (2011).","journal-title":"J. Neurosci."},{"key":"9385_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/glia.21255","volume":"60","author":"V Velanac","year":"2012","unstructured":"Velanac, V. et al. Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia 60, 203\u2013217 (2012).","journal-title":"Glia"},{"key":"9385_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nn.3281","volume":"16","author":"RM Stassart","year":"2013","unstructured":"Stassart, R. M. et al. A role for Schwann cell-derived neuregulin-1 in remyelination. Nat. Neurosci. 16, 48\u201354 (2013).","journal-title":"Nat. Neurosci."},{"key":"9385_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0896-6273(00)80128-2","volume":"16","author":"M Sereda","year":"1996","unstructured":"Sereda, M. et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16, 1049\u20131060 (1996).","journal-title":"Neuron"},{"key":"9385_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/hmg\/5.5.563","volume":"5","author":"C Huxley","year":"1996","unstructured":"Huxley, C. et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5, 563\u2013569 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"9385_CR32","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1101\/gad.258203","volume":"17","author":"M Jaegle","year":"2003","unstructured":"Jaegle, M. et al. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev. 17, 1380\u20131391 (2003).","journal-title":"Genes Dev."},{"key":"9385_CR33","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1038\/sj.onc.1205634","volume":"21","author":"L Li","year":"2002","unstructured":"Li, L. et al. The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland. Oncogene 21, 4900\u20134907 (2002).","journal-title":"Oncogene"},{"key":"9385_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/jnr.20601","volume":"81","author":"I Kobsar","year":"2005","unstructured":"Kobsar, I., Hasenpusch-Theil, K., Wessig, C., M\u00fcller, H. W. & Martini, R. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. J. Neurosci. Res. 81, 857\u2013864 (2005).","journal-title":"J. Neurosci. Res."},{"key":"9385_CR35","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1128\/MCB.14.3.1909","volume":"14","author":"D Wen","year":"1994","unstructured":"Wen, D. et al. Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol. Cell. Biol. 14, 1909\u20131919 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"9385_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2990.1988.tb00884.x","volume":"14","author":"S Ohara","year":"1988","unstructured":"Ohara, S. & Ikuta, F. Schwann cell responses during regeneration after one or more crush injuries to myelinated nerve fibres. Neuropathol. Appl. Neurobiol. 14, 229\u2013245 (1988).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"9385_CR37","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/brain\/124.11.2177","volume":"124","author":"S Sancho","year":"2001","unstructured":"Sancho, S., Young, P. & Suter, U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot\u2013Marie\u2013Tooth disease type 1A. Brain 124, 2177\u20132187 (2001).","journal-title":"Brain"},{"key":"9385_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1006\/mcne.2002.1109","volume":"20","author":"DB Parkinson","year":"2002","unstructured":"Parkinson, D. B., Langner, K., Namini, S. S., Jessen, K. R. & Mirsky, R. \u03b2-Neuregulin and autocrine mediated survival of Schwann cells requires activity of Ets family transcription factors. Mol. Cell. Neurosci. 20, 154\u2013167 (2002).","journal-title":"Mol. Cell. Neurosci."},{"key":"9385_CR39","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1523\/JNEUROSCI.16-19-06107.1996","volume":"16","author":"JB Grinspan","year":"1996","unstructured":"Grinspan, J. B., Marchionni, Ma, Reeves, M., Coulaloglou, M. & Scherer, S. S. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J. Neurosci. 16, 6107\u20136118 (1996).","journal-title":"J. Neurosci."},{"key":"9385_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuron.2004.09.028","volume":"14","author":"N Flames","year":"2004","unstructured":"Flames, N. et al. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 14, 251\u2013261 (2004).","journal-title":"Neuron"},{"key":"9385_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/glia.1038","volume":"34","author":"S Meintanis","year":"2001","unstructured":"Meintanis, S., Thomaidou, D., Jessen, K. R., Mirsky, R. & Matsas, R. The neuron-glia signal beta-neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34, 39\u201351 (2001).","journal-title":"Glia"},{"key":"9385_CR42","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2353\/ajpath.2010.090694","volume":"176","author":"B Kohl","year":"2010","unstructured":"Kohl, B., Fischer, S., Groh, J., Wessig, C. & Martini, R. MCP-1\/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy. Am. J. Pathol. 176, 1390\u20131399 (2010).","journal-title":"Am. J. Pathol."},{"key":"9385_CR43","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1523\/JNEUROSCI.0137-12.2012","volume":"32","author":"A Ishii","year":"2012","unstructured":"Ishii, A., Fyffe-Maricich, S. L., Furusho, M., Miller, R. H. & Bansal, R. ERK1\/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J. Neurosci. 32, 8855\u20138864 (2012).","journal-title":"J. Neurosci."},{"key":"9385_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuron.2010.12.003","volume":"69","author":"JM Newbern","year":"2011","unstructured":"Newbern, J. M. et al. Specific functions for ERK\/MAPK signaling during PNS development. Neuron 69, 91\u2013105 (2011).","journal-title":"Neuron"},{"key":"9385_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1101\/gad.230045.113","volume":"28","author":"ME Sheean","year":"2014","unstructured":"Sheean, M. E. et al. Activation of MAPK overrides the termination of myelin growth and replaces Nrg1\/ErbB3 signals during Schwann cell development and myelination. Genes Dev. 28, 290\u2013303 (2014).","journal-title":"Genes Dev."},{"key":"9385_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ng1195-281","volume":"3","author":"R Martini","year":"1995","unstructured":"Martini, R. et al. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 3, 281\u2013286 (1995).","journal-title":"Nat. Genet."},{"key":"9385_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0092-8674(92)90591-Y","volume":"4","author":"KP Giese","year":"1992","unstructured":"Giese, K. P. et al. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 4, 565\u2013576 (1992).","journal-title":"Cell"},{"key":"9385_CR48","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1212\/WNL.50.4.1061","volume":"50","author":"A Garc\u00eda","year":"1998","unstructured":"Garc\u00eda, A., Combarros, O., Calleja, J. & Berciano, J. Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 50, 1061\u20131067 (1998).","journal-title":"Neurology"},{"key":"9385_CR49","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/ene.13079","volume":"23","author":"F Manganelli","year":"2016","unstructured":"Manganelli, F. et al. Nerve conduction velocity in CMT1A: what else can we tell? Eur. J. Neurol. 23, 1566\u20131571 (2016).","journal-title":"Eur. J. Neurol."},{"key":"9385_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12282-015-0587-x","volume":"22","author":"S Ahmed","year":"2015","unstructured":"Ahmed, S., Sami, A. & Xiang, J. HER2-directed therapy: current treatment options for HER2-positive breast cancer. Breast Cancer 22, 101\u2013116 (2015).","journal-title":"Breast Cancer"},{"key":"9385_CR51","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/ng1195-274","volume":"11","author":"K Adlkofer","year":"1995","unstructured":"Adlkofer, K. et al. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11, 274\u2013280 (1995).","journal-title":"Nat. Genet."},{"key":"9385_CR52","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"9385_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)12115-K","volume":"200","author":"S Jung","year":"1995","unstructured":"Jung, S., Toyka, K. V. & Hartung, H. P. Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats. Neurosci. Lett. 200, 167\u2013170 (1995).","journal-title":"Neurosci. Lett."},{"key":"9385_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0022-510X(80)90198-7","volume":"48","author":"M Kadlubowski","year":"1980","unstructured":"Kadlubowski, M. & Hughes, R. A. The neuritogenicity and encephalitogenicity of P2 in the rat, guinea-pig and rabbit. J. Neurol. Sci. 48, 171\u2013178 (1980).","journal-title":"J. Neurol. Sci."},{"key":"9385_CR55","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jpain.2013.08.002","volume":"14","author":"L Di Cesare Mannelli","year":"2013","unstructured":"Di Cesare Mannelli, L. et al. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J. Pain 14, 1585\u20131600 (2013).","journal-title":"J. Pain"},{"key":"9385_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2337\/diabetes.49.2.157","volume":"49","author":"B Soria","year":"2000","unstructured":"Soria, B. et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157\u2013162 (2000).","journal-title":"Diabetes"},{"key":"9385_CR57","first-page":"233","volume":"1","author":"OA Meyer","year":"1979","unstructured":"Meyer, O. A., Tilson, H. A., Byrd, W. C. & Riley, M. T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1, 233\u2013236 (1979).","journal-title":"Neurobehav. Toxicol."},{"key":"9385_CR58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","volume":"20","author":"BJ Jones","year":"1968","unstructured":"Jones, B. J. & Roberts, D. J. The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod. J. Pharm. Pharmacol. 20, 302\u2013304 (1968).","journal-title":"J. Pharm. Pharmacol."},{"key":"9385_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0165-0270(97)00042-3","volume":"75","author":"K Klapdor","year":"1997","unstructured":"Klapdor, K., Dulfer, B. G., Hammann, A. & Van der Staay, F. J. A low-cost method to analyse footprint patterns. J. Neurosci. Methods 75, 49\u201354 (1997).","journal-title":"J. Neurosci. Methods"},{"key":"9385_CR60","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1083\/jcb.17.1.208","volume":"17","author":"ES Reynolds","year":"1963","unstructured":"Reynolds, E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 17, 208\u2013212 (1963).","journal-title":"J. Cell Biol."},{"key":"9385_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(79)90048-9","volume":"165","author":"JP Brockes","year":"1979","unstructured":"Brockes, J. P., Fields, K. L. & Raff, M. C. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165, 105\u2013118 (1979).","journal-title":"Brain Res."},{"key":"9385_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0022-1759(01)00404-5","volume":"254","author":"LJ Jones","year":"2001","unstructured":"Jones, L. J., Gray, M., Yue, S. T., Haugland, R. P. & Singer, V. L. Sensitive determination of cell number using the CyQUANT cell proliferation assay. J. Immunol. Methods 254, 85\u201398 (2001).","journal-title":"J. Immunol. Methods"},{"key":"9385_CR63","doi-asserted-by":"crossref","unstructured":"Kleitman, N., Wood, P. & Bunge, R. in Culturing Nerve Cells (Goslin, K. & Banker, G.) 545\u2013594 (MIT Press, Cambridge, 1998) .","DOI":"10.7551\/mitpress\/4913.003.0026"}],"updated-by":[{"DOI":"10.1038\/s41467-019-09886-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09385-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:02:16Z","timestamp":1671210136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09385-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9385"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09385-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735437177.793567813","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"29 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Michael W. Sereda was incorrectly associated with the Department of Cellular Neurophysiology, Hanover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany. The correct affiliations for Michael W. Sereda are Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 G\u00f6ttingen, Germany and Department of Clinical Neurophysiology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1467"}}